NEW YORK, June 11, 2026--KKR, together with the Kuwait Investment Authority (KIA), NVIDIA (NASDAQ: NVDA) and Vistra (NYSE: VST) today announced the launch of Helix Digital Infrastructure ("Helix"), a new company designed to deliver integrated infrastructure at the speed and scale required for hyperscalers to meet accelerating artificial intelligence (AI) demand. As building AI infrastructure becom...
NEW YORK, June 11, 2026--KKR, together with the Kuwait Investment Authority (KIA), NVIDIA (NASDAQ: NVDA) and Vistra (NYSE: VST) today announced the launch of Helix Digital Infrastructure ("Helix"), a new company designed to deliver integrated infrastructure at the speed and scale required for hyperscalers to meet accelerating artificial intelligence (AI) demand. As building AI infrastructure becomes increasingly complex, Helix will serve as a single coordination point for hyperscalers’ data cent
图片来源：Illustration by Fernando Capeto for Forbes; Photos by Suzanne Cordeiro/AFP/GettyImages; Ronaldo Schemidt/AFP/Getty Images 6月12日，SpaceX将以约1.8万亿美元的估值启动IPO，预计会为加州带来更多税收收入，因为数千名在那里生活和工作的员工即将身家大增，不得不缴...
图片来源：Illustration by Fernando Capeto for Forbes; Photos by Suzanne Cordeiro/AFP/GettyImages; Ronaldo Schemidt/AFP/Getty Images 6月12日，SpaceX将以约1.8万亿美元的估值启动IPO，预计会为加州带来更多税收收入，因为数千名在那里生活和工作的员工即将身家大增，不得不缴纳“百万富翁税”。而在另一边的得州，完全没有州级个人所得税。 埃隆·马斯克（Elon Musk）多年来不断抨击加州的税收、政治和营商环境，随后高调出走，将SpaceX总部迁至得州。如今，他职业生涯中最重大的财务事件，反倒可能给他曾经痛斥的州送上一笔巨额税收收入。 01 这便是SpaceX的IPO背后，一个尴尬的黑色幽默。 尽管公司总部迁至得州，但并没有让成千上万即将暴富的SpaceX员工随迁，他们仍然在洛杉矶地区生活和工作，并将面临加州所谓的“百万富翁税”。而不征收个人所得税的得州则无缘这笔意外之财。 SpaceX准备以每股135美元的价格出售5.556亿股股票，筹集约750亿美元资金，公司估值约为1.77万亿美元。对投资者来说，这一估值水平都不是登月级可以形容，简直是“登火星”级别。而对加州来说，公司估值冲上云霄之时，实实在在的好处却降落到洛杉矶县的土地上：真金白银的应税收入。 SpaceX目前总部位于得州的博卡奇卡（Boca Chica），公司在S-1文件中披露，全球员工超22,000人，包括人工智能公司xAI和社交媒体平台X的员工。公司未透露有多少员工仍在加州洛杉矶县霍桑市（Hawthorne）前总部“设计和建造可重复使用的火箭和航天器”，但霍桑去年6月的一份年度城市报告显示，这些员工人数为7661人。SpaceX还运营一家内部航空公司，可在需要时将驻扎在加州的工程人员从洛杉矶国际机场送往得州，这使得许多人得以继续住在加州。 罗斯·格伯（Ross Gerber）是圣莫尼卡投资公司Gerber Kawasaki的首席执行官，他的客户包括SpaceX的在职及前员工。他说：“SpaceX上市，加州经济将迎来繁荣。经济将获得巨大推力，税收收入也将大为充实。加州的预算100%依靠富人的资本利得税贡献。现状就是这样。” 02 这说得有点夸张，但加州预算官员或许希望情况能更加夸张一...
If you had the chance to meet Diego Maradona, what would you do? Smell him? That’s what our chief sports writer, Barney Ronay, did at the 2018 World Cup during Argentina’s first group game of the competition. To keep up with more of Barney’s adventures in his World Cup video diary, follow @guardian_sport on TikTok. Continue reading...
If you had the chance to meet Diego Maradona, what would you do? Smell him? That’s what our chief sports writer, Barney Ronay, did at the 2018 World Cup during Argentina’s first group game of the competition. To keep up with more of Barney’s adventures in his World Cup video diary, follow @guardian_sport on TikTok. Continue reading...
Nikolai Mentuk/iStock via Getty Images Parsons Corporation ( PSN ) has been awarded a $22M contract amendment by the Los Angeles County Metropolitan Transportation Authority (Metro) to deliver comprehensive multimodal infrastructure improvements along the I-605 corridor. The amendment extends Parsons’ existing contract by 3.5 years and aligns with Metro’s Board-adopted Multimodal Highway Investmen...
Nikolai Mentuk/iStock via Getty Images Parsons Corporation ( PSN ) has been awarded a $22M contract amendment by the Los Angeles County Metropolitan Transportation Authority (Metro) to deliver comprehensive multimodal infrastructure improvements along the I-605 corridor. The amendment extends Parsons’ existing contract by 3.5 years and aligns with Metro’s Board-adopted Multimodal Highway Investment Objectives. The project managed in partnership with Caltrans and the Gateway Cities Corridor Council of Governments, aims to alleviate severe congestion, enhance safety, and reduce commute times. To modernize the corridor, Parsons will oversee, the integration of managed lanes on the I-605 freeway. Optimized connectivity between local streets and freeway ramps, and community-focused upgrades, including new bicycle lanes, improved sidewalks, and enhanced transit access. "For over 20 years, Parsons has long been a trusted partner to Metro and the people of Los Angeles , helping them navigate the state – and world – seamlessly," said Mark Fialkowski , president, Infrastructure North America for Parsons. More on Parsons Parsons: Still Not An Attractive Opportunity Parsons Corporation (PSN) Presents at Bank of America 33rd Annual Industrials, Transportation and Airlines Key Leaders Conference Transcript Parsons Corporation (PSN) Q1 2026 Earnings Call Transcript Parsons lands fourth GARDEM award of 2026, totaling $218M Parsons wins $28M U.S. Air Force defense contract
Rogerio Xavier wants to set some things straight. First off, he says, no one staged a coup to topple him from the hedge-fund firm, SPX Capital, he had built into one of the biggest and most powerful in Brazil over the past two decades. And no, there were never any punches thrown as he and his co-partners haggled over how to restructure the firm and buoy its funds’ suddenly faltering returns. All t...
Rogerio Xavier wants to set some things straight. First off, he says, no one staged a coup to topple him from the hedge-fund firm, SPX Capital, he had built into one of the biggest and most powerful in Brazil over the past two decades. And no, there were never any punches thrown as he and his co-partners haggled over how to restructure the firm and buoy its funds’ suddenly faltering returns. All that chatter rippling through Brazilian financial circles blows out of proportion the occasional heated conversation between him and the partners, he says. “Speaking forcefully at times is just part of our nature — we’re traders, not nuns,” he says. “The fact that there’s debate doesn’t mean people cross certain lines.” However things went down when the SPX board gathered that afternoon in early May, what’s clear is this: Xavier, the firm’s principal shareholder, has been relegated to managing a far smaller chunk of money after posting several years of lackluster returns; the aggressive overseas expansion he had orchestrated, with offices in posh London and Manhattan neighborhoods, is all but over; and Bruno Pandolfi , a partner since the firm’s founding, has taken over management of the bulk of clients’ money. That pool of cash has shrunk steadily in recent years — from a peak of over 80 billion reais ($16 billion) to some 49 billion reais — as the firm’s subpar returns drove clients away. Then in March, things suddenly got a lot worse. The market gyrations triggered by the Iran war upended some of the firm’s trades, and its flagship fund, Nimitz , racked up its worst ever monthly loss — 5.5%. As Xavier tells it, the idea of a shakeup that would put one trader clearly in charge had been marinating for a while, and he eventually came to appreciate it was necessary. “We’ve had three or four years of mediocre performance,” Xavier, 59, said in an interview in Manhattan last month. He was in town for a few meetings and had set up shop in the temporary offices the firm was using ...
A diagnosis of pancreatic cancer is one of the most feared things in medicine. The disease has the highest mortality rate of all cancers. In 2026, roughly 67,530 Americans will be diagnosed with the disease in the U.S., and more than 52,740 will die from it, according to statistics from the Hirshberg Foundation for Pancreatic Cancer Research. On May 31, Revolution Medicines (NASDAQ: RVMD) presente...
A diagnosis of pancreatic cancer is one of the most feared things in medicine. The disease has the highest mortality rate of all cancers. In 2026, roughly 67,530 Americans will be diagnosed with the disease in the U.S., and more than 52,740 will die from it, according to statistics from the Hirshberg Foundation for Pancreatic Cancer Research. On May 31, Revolution Medicines (NASDAQ: RVMD) presented its Phase 3 trial findings for daraxonrasib, showing that this therapy, compared to chemotherapy, cut the risk of death by about 60% and more than doubled survival for patients with advanced pancreatic cancer. It is the first time any drug has pushed median overall survival past the one-year threshold in a Phase 3 trial for metastatic pancreatic cancer . On hearing that news, oncologists at a conference gave Revolution a standing ovation. Continue reading